MARKET

GSK

GSK

GSK PLC
NYSE
58.93
+0.39
+0.67%
After Hours: 59.30 +0.37 +0.63% 19:40 02/13 EST
OPEN
58.87
PREV CLOSE
58.54
HIGH
59.17
LOW
58.56
VOLUME
6.28M
TURNOVER
--
52 WEEK HIGH
60.37
52 WEEK LOW
31.37
MARKET CAP
120.10B
P/E (TTM)
15.77
1D
5D
1M
3M
1Y
5Y
1D
Jefferies Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
TipRanks · 1d ago
GMOI: This International ETF Is Off To A Strong Start
Seeking Alpha · 1d ago
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data
Seeking Alpha · 1d ago
GSK Advances Pediatric Antibiotic Strategy With New Gepotidacin Trial
TipRanks · 1d ago
GSK’s Arexvy RSV vaccine accepted for regulatory review in China for seniors
Seeking Alpha · 4d ago
GSK’s regulatory application for Arexvy accepted for review by China’s CDE
TipRanks · 4d ago
GSK RSV-Impfstoff Arexvy zur regulatorischen Überprüfung in China angenommen
Reuters · 4d ago
China Accepts GSK Arexvy RSV Vaccine for Regulatory Review in Adults Aged 60 and Older
Reuters · 4d ago
More
About GSK
GSK plc is a biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD to antibiotics. It develops and commercializes preclinical antibody-drug conjugate for Metastatic castration-resistant prostate cancer. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.